Syntax Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$296K Sell
1,203
-1
-0.1% -$274 0.26% 86
2023
Q2
$365K Sell
1,204
-170
-12% -$47.3K 0.29% 56
2023
Q1
$362K Sell
1,374
-66
-5% -$16.8K 0.27% 71
2022
Q4
$346K Sell
1,440
-220
-13% -$49.3K 0.29% 64
2022
Q3
$305K Sell
1,660
-74
-4% -$14.7K 0.26% 75
2022
Q2
$291K Buy
1,734
+515
+42% +$111K 0.24% 85
2022
Q1
$306K Sell
1,219
-295
-19% -$74.1K 0.26% 91
2021
Q4
$389K Buy
+1,514
New +$370K 0.29% 63

Other funds holding HCA

Syntax Advisors's HCA Position: Q3 2023 in Review

Syntax Advisors reduced its HCA Healthcare (HCA) stake by 0.08% in Q3 2023, selling an estimated $274 and leaving 1,203 shares worth $296K. The position accounts for 0.26% of the portfolio, ranked #86.

Syntax Advisors first reported a position in HCA in Q4 2021 and has held it in 8 quarters since. The position peaked at $389K in Q4 2021. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Syntax Advisors held 1,203 shares of HCA Healthcare worth $296K as of Q3 2023.
  • Syntax Advisors sold 1 HCA Healthcare share in Q3 2023, an estimated $274.
  • HCA Healthcare made up 0.26% of Syntax Advisors's portfolio in Q3 2023, its #86 holding.
  • Syntax Advisors first reported a position in HCA Healthcare in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's HCA Healthcare position peaked at $389K in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.